Hopefully you’ve had the chance to meet Salim and Roxanne from our Together series on GoBoldly.com. Salim is an antirejection researcher and Roxanne had a heart transplant 7 years ago this week and takes antirejection medicine every day.
I had the great pleasure of meeting Salim and Roxanne in person during our GOBOLDLY Together shoots earlier this year, and it brought back some memories for me.
Back in 1991, my father had a liver transplant. During that time, transplants weren’t as common as they are now. He was only the 12th person to have a liver transplant in the tristate area of Ohio, Indiana and Kentucky.
I was in the 7th grade at the time and, along with my mother, became an instant expert of all things transplant.
The doctors told us the new liver may last for 7 years. They weren’t really sure. But we knew we were going to do anything and everything to get through it as a family.
Antirejection drugs were a new concept to us. They had been around since the 1960s, allowing patients to receive non-identical donor organs so the person’s body wouldn’t reject the new organ. That medicine was the key to life as we now knew it; like oxygen.
Today, thanks to tenacious researchers like Salim, antirejection medicines are better than ever. Researchers are continuously learning new, updated methods to enable organ recipients to live longer, more robust lives.
As Salim says in this video, “Transplantation was simply lifesaving; now transplantation is life giving. And this difference from saving someone’s life to that individual having a life of giving is a huge achievement. And it is thanks to the general advances of medicine and the general advances of antirejection drugs.”
Lucky for us, my dad was able to live an amazing life for 15 additional years, not just 7. Each year we celebrated two birthdays – his real one on July 30 and his liver-versary on October 7. Quite remarkable.
Check out all of the GOBOLDLY advertisements at www.GoBoldly.com.
Learn more about the researchers, patients, and breakthroughs in progress at www.innovation.org.
Amber Lyons
Amber is senior director of public affairs at PhRMA. She eats, breathes and occasionally sleeps PhRMA’s national multi-year GOBOLDLY campaign, launched in January 2017. A Midwesterner who’s now spent close to 20 years in DC, Amber’s a recovering political junkie, world traveler, wine enthusiast and a kettlebell devotee. #goboldly
Amber Lyons
ICYMI: New approvals by the FDA in 2021 offer greater treatment options for patients
2020 FDA approvals show innovation despite COVID-19 pandemic challenges
Report: More than 1,300 medicines and vaccines in development to help fight cancer
New report shows more than 400 medicines and vaccines in development to tackle infectious diseases, including COVID-19
New report explores setbacks that bring future cancer success stories
What scientific experts are saying about vaccine safety
New report shows nearly 260 vaccines in development, including dozens for COVID-19
ICYMI: 2019 brings innovative medicines to patients
PhRMA comments to Congress on Cures 2.0 call to action
Nearly 140 medicines in development to treat mental illness
ICYMI: Fighting for a cure to ALS
"If Washington isn’t careful, we might leave innovation behind"
New report finds 15 new oncology therapies launched last year
Clinical Trials Awareness Week: Celebrating innovation in clinical research
Event: New era of medicine comes to Capitol Hill
Giving patients a voice: PhRMA launches Voters for Cures to support the next generation of treatments and cures
New report shows more than 160 medicines in development for diabetes and related conditions
Minority health matters
New report shows nearly 20 innovative medicines in development for sickle cell disease
130 medicines in development for asthma, allergies and other respiratory diseases
130 medicines in development for asthma, allergies and other respiratory diseases
Putting 2018 medicine approvals in context
New report shows nearly 300 cell and gene therapies in development
New report shows more than 300 skin disease medicines in development
Disrupting Alzheimer's
Event next week: Supporting the next generation of lifesaving medicines
Aspen Spotlight Health: Discussing the forefront of innovation
Nearly 60 biopharmaceutical researchers GoBoldly on Capitol Hill
New report and resources put cancer in context, showing more than 1,100 medicines and vaccines in development
Event tomorrow: Improving patient access to lifesaving medicines
Video: PhRMA CEO discusses biopharmaceutical supply chain at POLITICO event
Rare Disease Day: Unmet need inspires innovation
ICYMI: Why 2017 medicine approvals matter
ICYMI: Report highlights increasing prevalence for Alzheimer’s disease
New report and event examine the new era of vaccines
A new era in cancer
2017 Research & Hope Awards honor innovators in mental health
How biopharmaceutical collaboration is driving a new era of medicine
Working to harness the power of the body’s own immune system
Putting the bio in biotech: How Bay Area minds are powering biopharmaceutical innovation
Finding cures for incurable diseases
New report portrays flourishing pipeline
Examining the brain in The New Era of Medicine
Modernizing FDA regulations to advance a value-driven health care system
Fighting multiple sclerosis: New Together ad illuminates the journey of patient & scientist
ICYMI: Avalere and FasterCures develop new value framework from patient perspective
A New World of Medicine: New GOBOLDLY ads showcase groundbreaking scientific advancements
ICYMI: The New Era of Medicine initiative spotlights genomics in NYC
A new era in genomics
Mental health in the New Era of Medicine
This is not a special effect: New video shows the destruction of a rogue cell
ICYMI: New era of medicine initiative kicks off in Boston
Exploring the new era of medicine
Guest Post: Johnson and Johnson is celebrating outstanding scientists: Who will be next?
PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check
This is not a video game: New TV ad showcases the destruction of a cancer cell by immune system
VIDEO: PhRMA CEO discusses #GOBOLDLY campaign and White House meeting with CNNMoney’s Maggie Lake
The Value Collaborative: Advancing private market solutions to achieve better health, lower costs
VIDEO: PhRMA CEO joins CNBC’s Squawk on the Street to discuss industry campaign #GOBOLDLY
The 20-year journey yielding a new weapon against cancer
Going boldly together: New advancements and new anniversaries
GoBoldly
New Era of Medicine
Going boldly together: New advancements and new anniversaries
Going boldly together: New advancements and new anniversaries